Søgeresultater - Lusong Luo

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Yersiniabactin Synthetase

    Yersiniabactin Synthetase af Deborah A. Miller, Lusong Luo, Nathan J. Hillson, Thomas A. Keating, Christopher T. Walsh

    Udgivet 2002
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition

    BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition af Zhan Yao, Neilawattie M. Torres, Anthony Tao, Yijun Gao, Lusong Luo, Qi Li, Elisa de Stanchina, Omar Abdel‐Wahab, David B. Solit, Poulikos I. Poulikakos, Neal Rosen

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia

    Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia af Jennifer L. Ariazi, Kevin J. Duffy, David F. Adams, Duke M. Fitch, Lusong Luo, Melissa B. Pappalardi, Mangatt P. Biju, Erin Hugger DiFilippo, Tony Shaw, Ken Wiggall, Connie L. Erickson‐Miller

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice

    The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice af Lianhai Zhang, Yiqiang Liu, Xiaohong Wang, Zhiyu Tang, Shuangxi Li, Ying Hu, Xianglong Zong, Xiaojiang Wu, Zhaode Bu, Aiwen Wu, Ziyu Li, Zhongwu Li, Xiaozheng Huang, Ling Jia, Qiang Kang, Yong Liu, David Sutton, Lai Wang, Lusong Luo, Jiafu Ji

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in <i>BRAF</i>-Mutated Colorectal Cancers

    BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in <i>BRAF</i>-Mutated Colorectal Cancers af Zhiyu Tang, Xi Yuan, Rong Du, Shing-Hu Cheung, Guoliang Zhang, Jing Wei, Yuan Zhao, Yingcai Feng, Hao Peng, Yi Zhang, Yunguang Du, Xiaoxia Hu, Wenfeng Gong, Yong Liu, Yajuan Gao, Ye Liu, Rui Hao, Shengjian Li, Shaohui Wang, Jiafu Ji, Lianhai Zhang, Shuangxi Li, David Sutton, Wei Min, Changyou Zhou, Lai Wang, Lusong Luo

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors

    Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors af Jayesh Desai, Hui Gan, Catherine Barrow, Michael B. Jameson, Victoria Atkinson, Andrew Haydon, Michael Millward, Stephen Begbie, Michael P. Brown, Ben Markman, W. K. Patterson, Andrew G. Hill, Lisa G. Horvath, Adnan Nagrial, Gary Richardson, Christopher Jackson, Michael Friedlander, Phillip Parente, Ben Tran, Lai Wang, Yunxin Chen, Zhiyu Tang, Wendy Huang, John Wu, Dewan Zeng, Lusong Luo, Benjamin Solomon

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic <i>BRAF</i> by the Kinase Inhibitor SB-590885

    Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic <i>BRAF</i> by the Kinase Inhibitor SB-590885 af Alastair J. King, Denis R. Patrick, Roberta S. Batorsky, Maureen L. Ho, TạMinh Hiếu, Shu Yun Zhang, Rakesh Kumar, David W. Rusnak, Andrew K. Takle, David M. Wilson, Erin Hugger, Lifu Wang, Florian A. Karreth, Julie C. Lougheed, Jae Lee, David Chau, Thomas J. Stout, Earl W. May, Cynthia M. Rominger, Michael D. Schaber, Lusong Luo, Ami S. Lakdawala, Jerry L. Adams, Rooja G. Contractor, Keiran S.M. Smalley, Meenhard Herlyn, Michael M. Morrissey, David A. Tuveson, Pearl S. Huang

    Udgivet 2006
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

    Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin af Steven D. Knight, Nicholas D. Adams, Joelle L. Burgess, Amita M. Chaudhari, Michael G. Darcy, Carla A. Donatelli, Juan I. Luengo, K. A. NEWLANDER, Cynthia A. Parrish, Lance H. Ridgers, Martha A. Sarpong, Stanley J. Schmidt, Glenn S. Van Aller, Jeffrey D. Carson, Melody Diamond, P.A. Elkins, Christine Gardiner, Eric Garver, S. Gilbert, Richard R. Gontarek, Jeffrey R. Jackson, Kevin L. Kershner, Lusong Luo, Kaushik Raha, Christian Sherk, Chiu-Mei Sung, David Sutton, Peter J. Tummino, Ronald Wegrzyn, Kurt R. Auger, Dashyant Dhanak

    Udgivet 2010
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Antitumor activity of an allosteric inhibitor of centromere-associated protein-E

    Antitumor activity of an allosteric inhibitor of centromere-associated protein-E af Kenneth W. Wood, Latesh Lad, Lusong Luo, Xiangping Qian, Steven D. Knight, Neysa Nevins, Katjuša Brejc, David Sutton, Aidan G. Gilmartin, Penelope Chua, Radhika Desai, Stephen P. Schauer, Dean E. McNulty, Roland S. Annan, Lisa D. Belmont, Carlos Vázquez García, Yan Lee, Melody Diamond, Leo F. Faucette, Michele Giardiniere, ShuYun Zhang, Chiu-Mei Sun, Justin D. Vidal, Serge Lichtsteiner, William D. Cornwell, Joel Greshock, Richard Wooster, Jeffrey T. Finer, Robert A. Copeland, Pearl S. Huang, David J. Morgans, Dashyant Dhanak, Gustave Bergnes, Roman Sakowicz, Jeffrey R. Jackson

    Udgivet 2010
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295

    Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295 af Xiangping Qian, Andrew McDonald, Han-Jie Zhou, Nicholas D. Adams, Cynthia A. Parrish, Kevin J. Duffy, Duke M. Fitch, Rosanna Tedesco, Luke Ashcraft, Bing Yao, Hong Jiang, Jennifer Huang, Melchor V. Marin, Carrie E. Aroyan, Jianchao Wang, Seyed Ahmed, Joelle L. Burgess, Amita M. Chaudhari, Carla A. Donatelli, Michael G. Darcy, Lance H. Ridgers, K. A. NEWLANDER, Stanley J. Schmidt, Deping Chai, Mariela Colón, Michael N. Zimmerman, Latesh Lad, Roman Sakowicz, Stephen E. Schauer, Lisa D. Belmont, Ramesh Baliga, Daniel W. Pierce, Jeffrey T. Finer, Zhengping Wang, B. Paul Morgan, David J. Morgans, Kurt R. Auger, Chiu-Mei Sung, Jeff D. Carson, Lusong Luo, Erin Hugger, Robert A. Copeland, David Sutton, John D. Elliott, Jeffrey R. Jackson, Kenneth W. Wood, Dashyant Dhanak, Gustave Bergnes, Steven D. Knight

    Udgivet 2010
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: